The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers
Simple Summary MicroRNAs (miRNAs) are small RNA molecules that regulate gene
expression by blocking translation or inducing degradation of specific gene transcripts. The …
expression by blocking translation or inducing degradation of specific gene transcripts. The …
Current status of artificial intelligence applications in urology and their potential to influence clinical practice
Objective To investigate the applications of artificial intelligence (AI) in diagnosis, treatment
and outcome predictionin urologic diseases and evaluate its advantages over traditional …
and outcome predictionin urologic diseases and evaluate its advantages over traditional …
Artificial intelligence and its impact on urological diseases and management: a comprehensive review of the literature
BMZ Hameed, AVL S. Dhavileswarapu… - Journal of Clinical …, 2021 - mdpi.com
Recent advances in artificial intelligence (AI) have certainly had a significant impact on the
healthcare industry. In urology, AI has been widely adopted to deal with numerous …
healthcare industry. In urology, AI has been widely adopted to deal with numerous …
miR‐21‐5p, miR‐141‐3p, and miR‐205‐5p levels in urine—promising biomarkers for the identification of prostate and bladder cancer
Background Early detection of cancers improves patients' survival and decreases the
treatment cost. Unfortunately, the current methods for diagnosis of bladder and prostate …
treatment cost. Unfortunately, the current methods for diagnosis of bladder and prostate …
The translational potential of microRNAs as biofluid markers of urological tumours
A Fendler, C Stephan, GM Yousef… - Nature Reviews …, 2016 - nature.com
MicroRNAs (miRNAs) are secreted by cells in vesicles, bound in a ribonucleoprotein
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …
Role of exosomal miRNA in bladder cancer: a promising liquid biopsy biomarker
Bladder cancer (BCa) is the most prevalent neoplasia of the urinary tract. Unfortunately,
limited improvements in effective BCa management have meant that it remains a …
limited improvements in effective BCa management have meant that it remains a …
Increased accuracy of a novel mRNA‐based urine test for bladder cancer surveillance
R Pichler, J Fritz, G Tulchiner, G Klinglmair… - Bju …, 2018 - Wiley Online Library
Objectives To evaluate the diagnostic accuracy of the Xpert Bladder Cancer (BC) Monitor,
compared with cystoscopy and cytology in the oncological follow‐up of non‐muscle …
compared with cystoscopy and cytology in the oncological follow‐up of non‐muscle …
Urinary markers in bladder cancer: an update
G Santoni, MB Morelli, C Amantini, N Battelli - Frontiers in oncology, 2018 - frontiersin.org
Bladder cancer (BC) is ones of the most common cancer worldwide. It is classified in muscle
invasive (MIBC) and muscle non-invasive (NMIBC) BC. NMIBCs frequently recur and …
invasive (MIBC) and muscle non-invasive (NMIBC) BC. NMIBCs frequently recur and …
Liquid biopsy biomarkers in bladder cancer: a current need for patient diagnosis and monitoring
I Lodewijk, M Dueñas, C Rubio… - International journal of …, 2018 - mdpi.com
Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence
and recurrence rates, as well as the limited advances in effective disease management …
and recurrence rates, as well as the limited advances in effective disease management …
Transforming disease diagnosis and management: a comprehensive review of AI-driven urine analysis in clinical medicine
Urinalysis is a significant diagnostic tool for the detection of various diseases. The recent
surge in the applications of artificial intelligence (AI) has revolutionized the medical industry …
surge in the applications of artificial intelligence (AI) has revolutionized the medical industry …